Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK933776 in Geographic Atrophy
NCT01342926Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2011
- Primary completion
- Apr 2016
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of GSK933776 in geographic atrophy (GA), sponsored by GSK. Started Jun 2011; status: completed.
02
Drugs
GSK933776
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT01342926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342926.